175 related articles for article (PubMed ID: 19088695)
1. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.
Havekes B; Lai EW; Corssmit EP; Romijn JA; Timmers HJ; Pacak K
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):419-29. PubMed ID: 19088695
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Comparative Study of 18 F-FDOPA PET/CT Versus 123 I-MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma.
Sung C; Lee HS; Lee DY; Kim YI; Kim JE; Lee SJ; Oh SJ; Sung TY; Lee YM; Kim YH; Kim BJ; Koh JM; Lee SH; Ryu JS
Clin Nucl Med; 2024 Jan; 49(1):27-36. PubMed ID: 38054497
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma.
Zhang X; Wakabayashi H; Hiromasa T; Kayano D; Kinuya S
Semin Nucl Med; 2023 Jul; 53(4):503-516. PubMed ID: 36641337
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of adrenal masses using 18 F-FDOPA PET/CT in patients suspected with pheochromocytoma.
Kim SJ; Park CY; Kwon H; Kim YH
Nucl Med Commun; 2024 Jan; 45(1):86-92. PubMed ID: 37901929
[TBL] [Abstract][Full Text] [Related]
5. Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.
Jimenez C; Chin BB; Noto RB; Dillon JS; Solnes L; Stambler N; DiPippo VA; Pryma DA
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36472300
[TBL] [Abstract][Full Text] [Related]
6. Imaging of Pheochromocytomas and Paragangliomas.
Timmers HJLM; Taïeb D; Pacak K; Lenders JWM
Endocr Rev; 2024 May; 45(3):414-434. PubMed ID: 38206185
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Pheochromocytomas and Abdominal Paragangliomas.
Granberg D; Juhlin CC; Falhammar H
J Clin Endocrinol Metab; 2021 Apr; 106(5):e1937-e1952. PubMed ID: 33462603
[TBL] [Abstract][Full Text] [Related]
8. Caution on the Use of
Needleman L; Enamandram S; Annes JP
JCEM Case Rep; 2023 Nov; 1(6):luad149. PubMed ID: 38045868
[TBL] [Abstract][Full Text] [Related]
9. A Case of Pheochromocytoma With Coagulation Necrosis Due to Hypertensive Crisis Aggravated by Contrast-Enhanced CT Scan and Negative 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy.
Kobayashi A; Ishinoda Y; Uto A; Ogata S; Oshima N
Cureus; 2024 Mar; 16(3):e56878. PubMed ID: 38659567
[No Abstract] [Full Text] [Related]
10. Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy.
Ruike Y; Suzuki S; Yokote K
Clin Nucl Med; 2024 May; 49(5):419-426. PubMed ID: 38546331
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis.
Wakabayashi N; Watanabe S; Abe T; Takenaka J; Hirata K; Kimura R; Sakamoto K; Shinohara N; Kudo K
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38656630
[TBL] [Abstract][Full Text] [Related]
12. Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.
Parenti G; Zampetti B; Rapizzi E; Ercolino T; Giachè V; Mannelli M
J Oncol; 2012; 2012():872713. PubMed ID: 22851969
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytoma and paraganglioma at a children's hospital in Argentina. A case series.
Deregibus MI; Pompozzi LA; Sansó G
Arch Argent Pediatr; 2024 Apr; 122(2):e202310099. PubMed ID: 37999372
[TBL] [Abstract][Full Text] [Related]
14. Approach to the patient: Concept and application of targeted radiotherapy in the paraganglioma patient.
Pacak K; Taieb D; Lin FI; Jha A
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38652045
[TBL] [Abstract][Full Text] [Related]
15. Radio theranostics in paragangliomas and pheochromocytomas.
Wohlwend SP; Arques PB;
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024 May; ():500017. PubMed ID: 38735639
[TBL] [Abstract][Full Text] [Related]
16. [French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network].
de la Fouchardière C; Haissaguerre M; Decaussin-Petrucci M; Renaudin K; Deschamps F; Mirallié E; Murez T; Pattou F; Rocher L; Savoie PH; Faron M; Taieb D; Tabarin A; Bertherat J; Gimenez-Roqueplo AP; Amar L; Baudin E; Libé R
Bull Cancer; 2023 Oct; 110(10):1063-1083. PubMed ID: 37573200
[TBL] [Abstract][Full Text] [Related]
17. New Biology of Pheochromocytoma and Paraganglioma.
Pacak K
Endocr Pract; 2022 Dec; 28(12):1253-1269. PubMed ID: 36150627
[TBL] [Abstract][Full Text] [Related]
18. Massive pheochromocytoma.
Anai T; Oka K; Yokota Y; Nishimura Y; Hagiya H; Otsuka F
Clin Case Rep; 2020 Nov; 8(11):2308-2309. PubMed ID: 33235787
[TBL] [Abstract][Full Text] [Related]
19. MALIGNANT PARAGANGLIOMA NON-RESPONSIVE TO MIBG IN MEN2A SYNDROME.
Lider S; Gheorghiu M; Milos I; Badiu C
Acta Endocrinol (Buchar); 2022; 18(4):536-537. PubMed ID: 37152873
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
